Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immunology
Biotech
Kymera pivots to immunology, seeks partners for cancer assets
Kymera is pivoting to immunology, with plans to only develop cancer programs beyond phase 1 through partnerships.
Gabrielle Masson
Nov 1, 2024 11:46am
Teva brings biotech ethos to drug development, exec says
Oct 15, 2024 4:33pm
I&I biotech Triveni raises $115M for preclinical antibodies
Oct 2, 2024 7:00am
UCLA scoops $120M gift for immunology and immunotherapy site
Aug 28, 2024 9:25am
GSK signs $7B biobuck respiratory, immunology pact with Flagship
Jul 29, 2024 8:33am
AbbVie turns up the M&A heat with $250M Celsius buy
Jun 27, 2024 11:00am
